Related references
Note: Only part of the references are listed.Primidone blocks RIPK1-driven cell death and inflammation
Theresa Riebeling et al.
CELL DEATH AND DIFFERENTIATION (2021)
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
Gang Xu et al.
CELL RESEARCH (2021)
Current treatment and future challenges in ROS1-and ALK-rearranged advanced non-small cell lung cancer
Jordi Remon et al.
CANCER TREATMENT REVIEWS (2021)
ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
Jiali Cai et al.
CELL DEATH & DISEASE (2021)
Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1
Yulin Ouyang et al.
CELLS (2021)
Discovery of a cooperative mode of inhibiting RIPK1 kinase
Huyan Meng et al.
CELL DISCOVERY (2021)
ZBP1 mediates interferon-induced necroptosis
Daowei Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Astilbin protects chicken peripheral blood lymphocytes from cadmium-induced necroptosis via oxidative stress and the PI3K/Akt pathway
Chi Xin et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2020)
Combined Effect of Midazolam and Bone Morphogenetic Protein-2 for Differentiation Induction from C2C12 Myoblast Cells to Osteoblasts
Yukihiko Hidaka et al.
PHARMACEUTICS (2020)
Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex
Jinho Seo et al.
CELL DEATH AND DIFFERENTIATION (2020)
Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation
Lucie Laurien et al.
NATURE COMMUNICATIONS (2020)
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Cilia interactome with predicted protein-protein interactions reveals connections to Alzheimer's disease, aging and other neuropsychiatric processes
Kalyani B. Karunakaran et al.
SCIENTIFIC REPORTS (2020)
Hair growth promotion by necrostatin-1s
Mei Zheng et al.
SCIENTIFIC REPORTS (2020)
Computational discovery of therapeutic candidates for preventing preterm birth
Brian L. Le et al.
JCI INSIGHT (2020)
TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma
Biswajit Podder et al.
CELL DEATH AND DIFFERENTIATION (2019)
Death by inflammation: drug makers chase the master controller
Cormac Sheridan
NATURE BIOTECHNOLOGY (2019)
Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection
Mengtao Cao et al.
CELL DEATH AND DIFFERENTIATION (2019)
Targeting RIPK1 for the treatment of human diseases
Alexei Degterev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Junying Yuan et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment
Mihael Vucur et al.
DISEASE MARKERS (2018)
Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis
Huyan Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy
David H. Munn et al.
CANCER RESEARCH (2018)
LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
Lucia Taraborrelli et al.
NATURE COMMUNICATIONS (2018)
Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model
Sung Won Lee et al.
SCIENTIFIC REPORTS (2018)
Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways
Jian-Hong Shi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis
Fabienne Le Cann et al.
FEBS JOURNAL (2017)
SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination
Ran Wei et al.
GENES & DEVELOPMENT (2017)
Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
Kelby W. Wegner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury
Sofie Martens et al.
CELL DEATH & DISEASE (2017)
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Jiefei Geng et al.
NATURE COMMUNICATIONS (2017)
KLHDC10 Deficiency Protects Mice against TNFα-Induced Systemic Inflammation
Namiko Yamaguchi et al.
PLOS ONE (2016)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis
A. Fauster et al.
CELL DEATH & DISEASE (2015)
Necrosis-dependent and independent signaling of the RIP kinases in inflammation
Kenta Moriwaki et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
An essential role for TAK1 in the contact hypersensitivity response
Yan G. Zhao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response Syndrome
Linde Duprez et al.
IMMUNITY (2011)
Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs
J. Silke et al.
CELL DEATH AND DIFFERENTIATION (2010)
Regulation of Lipopolysaccharide-Induced Inflammatory Response and Endotoxemia by β-Arrestins
Katie J. Porter et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Comparison of the Luminescent ADP-Glo Assay to a Standard Radiometric Assay for Measurement of Protein Kinase Activity
Jasbinder Sanghera et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases
Hicham Zegzouti et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2009)
Apoptosis and caspases regulate death and inflammation in sepsis
Richard S. Hotchkiss et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Share Paper
